The global Peptide Therapeutics Market is estimated to be valued at US$ 44,386.9 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Peptide therapeutics are short chains of amino acids linked by peptide (amide) bonds. They can be used as alternatives to conventional small molecule drugs due to their high potency, specificity and low toxicity. They are used to treat conditions such as cancer, metabolic disorders, cardiovascular diseases etc.
Market key trends:
One of the key trends in the peptide therapeutics market size is the rising investment in R&D of novel peptide drugs. Peptide-based drugs have advantages over small molecules such as higher target specificity and lower toxicity. Major players are investing heavily in development of novel peptide drugs for various indications. For instance, Amgen invested around $5 billion in 2019 on R&D activities including development of novel peptide drugs for conditions such as cancer and cardiovascular diseases. In addition, development of optimized drug delivery methods for peptides is also accelerating the market growth. New technologies such as nanoparticle formulations are being developed to enhance stability, bioavailability and half-life of peptide drugs.
Segment Analysis
Peptide therapeutics market is segmented into proprietary peptides, generic peptides, and drug delivery systems. The proprietary peptides segment dominates the market and accounts for around 60% market share due to the prevalence of clinically validated peptides and rising adoption of proprietary peptides to address specific disease conditions.
Key Takeaways
The global peptide therapeutics market is expected to witness high growth, exhibiting a CAGR of 6.6% over the forecast period, due to increasing R&D investments by key players and rising prevalence of metabolic and gastrointestinal disorders.
Regional Analysis
North America dominates the global peptide therapeutics market and is expected to continue its dominance over the forecast period. This is attributed to the advanced healthcare infrastructure and rising incidence of chronic diseases in the region. Asia Pacific exhibits the fastest growth due to increasing healthcare spending and presence of huge patient population.
Key players
Key players operating in the peptide therapeutics market are Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Get more insights on this topic: https://www.newsstatix.com/peptide-therapeutics-market-share-and-opportunity-analysis-2023-2030/
Comments
0 comment